Climate change solutions
We deliver game-changing environmental solutions that have a real impact for people around the globe.
Featured
Our impact
For more almost 60 years, we have been building innovative solutions to the biggest environmental challenges — from the soil to the sky.
Featured
About us
Guided by science and economics, and committed to climate justice, we work in the places, on the projects and with the people that can make the biggest difference.
Featured
Get involved
If we act now — together — there’s still time to build a future where people, the economy and the Earth can all thrive. Every one of us has a role to play. Choose yours.
Featured
News and stories
Stay informed and get inspired with our in-depth reporting about the people and ideas making a difference, insight from our experts and the latest environmental progress.
Featured
    • EDF Health

    Chemical Concerns – Insights on Air Pollution, Public Health, and Chemical Safety

    Pace and outcomes of EPA new chemical reviews appear to be on track

    Posted: in Health policy, Regulation, TSCA reform

    Written By

    Share

    Richard Denison, Ph.D., is a Lead Senior Scientist.

    The Environmental Protection Agency (EPA) yesterday updated its website to provide a current snapshot of the status of new chemical reviews it has been conducting under last year’s amendments to the Toxic Substances Control Act (TSCA).  The statistics show that, despite being faced immediately with a substantial increase in responsibilities and workload as a result of the major changes made to TSCA, EPA has made enormous progress in implementing the new requirements.

    Because the changes made by the Lautenberg Act to TSCA’s new chemicals program were both extensive and immediately effective upon enactment, a temporary backlog developed while EPA implemented the new requirements in reviewing both chemicals that were under review at the time of the law’s passage and those that came in subsequently.

    Yesterday’s announcement and the related statistics indicate that the backlog has markedly declined since January, falling from 300 to below 150 cases.  In a press release EPA says it is committed to eliminating the backlog entirely by July.

    Equally important in the statistics is the fact that many more chemicals are being subject to orders imposing conditions on their commercialization, relative to the old law:  For about half of the reviews completed to date, EPA has issued a consent order.  This is to be expected:  The new law requires EPA to issue such orders whenever it either lacks sufficient information to evaluate a new chemical, or makes a risk- or exposure-based finding that indicates potential concern.  In such cases, the orders must impose conditions sufficient to mitigate the concern.

    Yesterday’s announcement is welcome.  EPA needs to stay the course.  And the chemical industry needs to recognize that restoring public and market confidence in our chemical safety system requires a robust new chemicals program.

    Related Posts